Signification of forkhead box A1 (FOXA1) expression in thyroid cancers

[1]  Hongwei Zhou,et al.  miR-132 Targets FOXA1 and Exerts Tumor-Suppressing Functions in Thyroid Cancer , 2019, Oncology research.

[2]  Xiaojun Yang,et al.  Expression and prognosis analyses of forkhead box A (FOXA) family in human lung cancer. , 2019, Gene.

[3]  P. Ng,et al.  Dysregulation of miR‐431 and target gene FOXA1 in intestinal tissues of infants with necrotizing enterocolitis , 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[4]  E. Anagnostou,et al.  Different outcomes in sporadic versus familial medullary thyroid cancer , 2018, Head & neck.

[5]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[6]  R. Kittler,et al.  FoxA transcription factor Fork head maintains the intestinal stem/progenitor cell identities in Drosophila. , 2018, Developmental biology.

[7]  Z. Baloch,et al.  Special types of thyroid carcinoma , 2018, Histopathology.

[8]  N. Li,et al.  Silencing FOXA1 gene regulates liver cancer cell apoptosis and cell proliferation. , 2018, European review for medical and pharmacological sciences.

[9]  Qi Zhang,et al.  MicroRNA-30a-5p suppresses proliferation, invasion and tumor growth of hepatocellular cancer cells via targeting FOXA1. , 2017, Oncology letters.

[10]  A. Ribechini,et al.  Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies , 2017, Nature Reviews Endocrinology.

[11]  D. Nonaka.  A study of FoxA1 expression in thyroid tumors. , 2017, Human pathology.

[12]  R. Lloyd,et al.  WHO classification of tumours of endocrine organs , 2017 .

[13]  Yin-ling Xiu,et al.  The transcription factor FOXA1 induces epithelial ovarian cancer tumorigenesis and progression , 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[14]  T. Takano.  Natural history of thyroid cancer [Review]. , 2017, Endocrine journal.

[15]  S. Wajner,et al.  Advances and controversies in the management of medullary thyroid carcinoma , 2017, Current opinion in oncology.

[16]  Bohua Chen,et al.  MicroRNA-212 suppresses the proliferation and migration of osteosarcoma cells by targeting forkhead box protein A1. , 2016, Experimental and therapeutic medicine.

[17]  Fabien C. Lamaze,et al.  FOXA and master transcription factors recruit Mediator and Cohesin to the core transcriptional regulatory circuitry of cancer cells , 2016, Scientific Reports.

[18]  K. Kaestner,et al.  The Pioneer Transcription Factor FoxA Maintains an Accessible Nucleosome Configuration at Enhancers for Tissue-Specific Gene Activation. , 2016, Molecular cell.

[19]  Dan Li,et al.  miR-194 inhibits the proliferation, invasion, migration, and enhances the chemosensitivity of non-small cell lung cancer cells by targeting forkhead box A1 protein , 2016, Oncotarget.

[20]  P. Zoppoli,et al.  Revising the embryonic origin of thyroid C cells in mice and humans , 2015, Development.

[21]  Wei Yang,et al.  MicroRNA-212 suppresses tumor growth of human hepatocellular carcinoma by targeting FOXA1 , 2015, Oncotarget.

[22]  F. Gemignani,et al.  Medullary thyroid carcinoma (MTC) and RET proto-oncogene: mutation spectrum in the familial cases and a meta-analysis of studies on the sporadic form. , 2013, Mutation research.

[23]  J. Carroll,et al.  Pioneer factors in hormone-dependent cancers , 2012, Nature Reviews Cancer.

[24]  Gina M. Bernardo,et al.  FOXA1: a transcription factor with parallel functions in development and cancer. , 2012, Bioscience reports.

[25]  T. Hickey,et al.  FOXA1: master of steroid receptor function in cancer , 2011, The EMBO journal.

[26]  D. Parkin,et al.  Trends in the incidence of cancer in the Sousse region, Tunisia, 1993–2006 , 2010, International journal of cancer.

[27]  K. Kaestner,et al.  The FoxA factors in organogenesis and differentiation. , 2010, Current opinion in genetics & development.

[28]  S. le Cessie,et al.  Calcitonin and carcinoembryonic antigen doubling times as prognostic factors in medullary thyroid carcinoma: a structured meta‐analysis , 2010, Clinical endocrinology.

[29]  M. Loda,et al.  FOXA1 Is a Potential Oncogene in Anaplastic Thyroid Carcinoma , 2009, Clinical Cancer Research.